ABC | Volume 112, Nº2, Fevereiro 2019

Artigo de Revisão Fontes-Carvalho et al O ano de 2018 em cardiologia: ABC cardiol e RPC em resumo Arq Bras Cardiol. 2019; 112(2):193-200 1. Nascimento BR, Brant LCC, Oliveira GMM, Malachias MVB, Reis GMA,Teixeira RA, et al. Epidemiologia das doenças cardiovasculares em paísesde Língua Portuguesa: dados do “Global Burden of Disease”, 1990 a 2016. Arq Bras Cardiol. 2018;110(6):500-11. 2. Fontes-Carvalho R, Gonçalves L. The Portuguese Journal of Cardiology. Eur Heart J. 2018;39(10):829-30. 3. Rochitte CE. The New Impact Factor of the Arquivos Brasileiros de Cardiologia (ABC Cardiol), 1.318: An Achievement of the SBC for Our Scientific Community. Arq Bras Cardiol. 2018;111(1):1-3. 4. Timóteo AT, Mimoso J; em nome dos investigadores do Registro Nacional de Síndromes Coronárias Agudas. Portuguese Registry of Acute Coronary Syndromes (ProACS): 15 years of a continuous and prospective registry. Rev Port Cardiol. 2018;37(7):563-73. 5. Lawesson SS, Alfredsson J, Fredrikson M, Swahn E. Time trends in STEMI – improved treatment and outcome but still a gender gap:a prospective observational cohort study from the SWEDEHEART registry. BMJ Open. 2012;2(2):e000726. 6. Herrett E, Smeeth L, Walker L, Weston C. MINAP Academic Group. The Myocardial Ischaemia National Audit Project (MINAP). Heart. 2010; 96(16):1264-7. 7. Pereira H, Calé R, Pinto FJ, Pereira E, Caldeira D, Mello S,et al. Centers participating in the Stent for Life Initiative Portugal. Factors influencing the patient delay to primary angioplasty in myocardial infarction with ST- segment elevation (STEMI): The Stent for life initiative in Portugal. Rev Port Cardiol. 2018; 37(5):409-21. 8. Nallamothu BK, Normand SL, Wang Y, Hofer TP, Brush JE Jr, Messenger JC, et al. Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet. 2015;385(9973):1114-22. 9. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: everyminute of delay counts. Circulation. 2004;109(10):1223-5. 10. De Luca G, Suryapranata H, Zijlstra F, van ‘t Hof AW, Hoorntje JC, Gosselink AT, et al. Symptom-onset-toballoon time andmortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol. 2003;42(6):991-7. 11. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018 Aug 25 [ahead of print] 12. Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS,et al.Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med .2017;376(19):1824–34. 13. Gotberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, et al. iFRSWEDEHEART Investigators. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med .2017;376(19)1813–23. 14. CookCM,JeremiasA,PetracoR,SenS,NijjerS,Shun-ShinMJ,etal.Fractional flow reserve/instantaneous wave-free ratio discordance in angiographically intermediate coronary stenoses: an analysis using Doppler-derived coronary flowmeasurements. JACC Cardiovasc Interv. 2017;10(24):2514-24. 15. Menezes MN, Francisco AR, Ferreira PC, Jorge C, Torres D, Cardoso P, et al. Comparative analysis of fractional flow reserve and instantaneous wave-free ratio: Results of a five-year registry. Rev Port Cardiol. 2018;37(6):511-20. 16. Lee JM, Shin ES, NamCW, Doh JH, Hwang D, Park J, et al. Clinical outcomes according to fractional flow reserve or instantaneous wave-free ratio in deferred lesions. JACC Cardiovasc Interv. 2017;10(24):2502-10. 17. Kern MJ, Seto AH. Is instantaneous wave-free ratio a new standard of care for physiologic assessment of coronary lesions?More questions than answers. Circulation. 2017;136(24):2295-7. 18. Bravo Baptista S, Raposo L. Coronary pressure (sometimes) lies. Rev Port Cardiol. 2018;37(6):521-3. 19. Farsky PS, Hirata MH, Arnoni RT, Almeida AFS, Issa M, Lima PH. Persistent inflammatory activity in blood cells and artery tissue from patients with previous bare metal stent. Arq Bras Cardiol. 2018; 111(2):134-41. 20. Borges JM, Almeida PA, NascimentoMM, Barreto Filho JA, Rosa MB, Sousa AC. Factors associated with inadequate management of antiplatelet agents in perioperative period of non- cardiac surgeries. Arq Bras Cardiol.2018; 111(4):596-604. 21. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC guidelines for themanagement of acutemyocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST- segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. 22. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients pre-senting without persistent ST-segment elevation. Eur Heart J. 2016;37(3):267-315. 23. DondoTB,HallM,WestRM,JernbergT,LindahlB,BuenoH,etal. β -Blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction. J AmColl Cardiol. 2017;69(22):2710-20. 24. Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, et al. β -Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13):1340-9. 25. Timóteo AT, Rosa SA, Cruz M, Moreira RI, Carvalho R, Ferreira ML, et al. What is the role of beta-blockers in a contemporary treatment cohort of patients with acute coronary syndromes? A propensity-score matching analysis. Rev Port Cardiol. 2018;37(11):901-8. Referências e tratamento da doença. Foram também apresentados dados populacionais e epidemiológicos de particular importância para os países de língua portuguesa. Contribuição dos autores Concepção e desenho da pesquisa, redação do manuscrito e revisão crítica do manuscrito quanto ao conteúdo intelectual importante: Fontes-Carvalho R, Oliveira GMM, Oliveira GMM, Rochitte CE. Potencial conflito de interesses Declaro não haver conflito de interesses pertinentes. Fontes de financiamento Opresente estudo não teve fontes de financiamento externas. Vinculação acadêmica Nãohávinculaçãodesteestudoaprogramasdepós‑graduação. 199